Uptake Mechanism of Pitavastatin, a New Inhibitor of HMG-CoA Reductase, in Rat Hepatocytes

Drug Metabolism and Pharmacokinetics

Volumn 18, Issue 4, 2003, Pages 245-251

  Shimada, Syunsuke ^a   Fujino, Hideki ^a   Kojima, Junji ^a   Morikawa, Takashi ^b   Moriyasu, Matsuko ^b  

^a KOWA COMPANY LTD   (Japan)

^b Panapharm Laboratories Co Ltd   (Japan)

Author keywords

carrier mediated uptake; HMG CoA reductase inhibitor; Na+ independent multispecific anion transporter; pitavastatin; rat hepatocyte

Indexed keywords

EID: 2442676360     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.18.245     Document Type: Article

References (33)

1. Igel, M., Sudhop, T. and von Bergmann K.: Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins). Eur. J. Clin. Pharmacol. 57: 357-364 (2001).
2. Ishikawa, T., Allikimets, R., Dean, M., Higgins, C., Ling, V. and Wain, H. M.: New nomenclature of human ABC transporter genes. Xeno. Metab. Disp., 15: 8-19 (2000).
3. Shitara, Y., Itoh, T., Sato, H., Li, A. P. and Sugiyama, Y.: Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A. J Pharmacol Exp. Ther., 304: 610-616 (2003).
4. Muck, W., Mai, I., Fritsche, L., Ochmann, K., Rohde, G., Unger, S., Johne, A., Bauer, S., Budde, K., Roots, I., Neumayer, H. H. and Kuhlmann, J.: Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients. Clin. Pharmacol. Ther., 65: 251-261 (1999).
5. Aoki, T., Nishimura, H., Nakagawa, S., Kojima, J.,Suzuki, H., Tamaki, T., Wada, Y., Yokoo, N., Sato, F.,Kimata, H., Kitahara, M., Toyoda, K., Sakashita, M. and Saito, Y.: Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneim. Forsch. J Drug Res., 47: 904-909 (1997).
6. Suzuki, H., Aoki, T., Tamaki, T., Sato, F., Kitahara, M. and Saito, Y.: Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs. Atherosclerosis, 146: 259-270 (1999).
7. Kajinami, K., Mabuchi, H. and Saito, Y.: NK-104: a novel synthetic HMG-CoA reductase inhibitor. Expert Opin. Investig. Drugs, 9: 2653-2661 (2000).
8. Kimata, H., Fujino, H., Koide, T., Yamada, Y.,Tsunenari, Y. and Yanagawa, Y.: Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (1): Absorption, distribution, metabolism and excretion in rats. Xeno. Metab. Disp., 13: 484-498 (1998).
9. Koga, T., Fukuda, K., Shimada, Y., Fukami, M., Koike, H. and Tsujita, Y.: Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat. Eur. J. Biochem., 209: 315-319 (1992).
10. Tse, F. L., Smith, H. T., Ballard, F. H. and Nicoletti, J.: Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkey. Biopharm. Drug. Dispos., 11: 519-531 (1990).
11. Bocan, T. M., Ferguson, E., McNally, W., Uhlendorf, P. D., Bak Mueller. S., Dehart, P., Sliskovic, D. R., Roth, B. D., Krause, B. R. and Newton, R. S.: Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors. Biochim. Biophys. Acta., 1123: 133-144 (1992).
12. Bischoff, H., Angerbauer, R., Boberg, M., Petzinna, D., Schmidt, D., Steinke, W. and Thomas, G.: Preclinical review of cerivastatin sodium-a step forward in HMG-CoA reductase inhibition. Atherosclerosis., 139: S7-S13 (1998).
13. Yamazaki, M., Suzuki, H., Hanano, M. and Sugiyama, Y.: Different relationships between cellular ATP and hepatic uptake among taurocholate, cholate, and organic anions. Am. J. Physiol., 264: G693-G701 (1993).
14. Yamazaki, M., Suzuki, H., Hanano, M., Tokui, T.,Komai, T. and Sugiyama, Y.: Na+-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am. J. Physiol., 264, G36-G44 (1993).
15. Tokui, T., Nakai, D., Nakagomi, R., Yawo, H., Abe, T. and Sugiyama, Y.: Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, oatp2. Pharm. Res., 16: 904-908 (1999).
16. Hirayama, M., Yoshimura, Y. and Moriyasu, M.: Carrier-mediated of cerivastatin in primary cultured rat hepatocytes. Xeno. Metab. Disp., 15: 219-225 (2000).
17. Horiuti, Y., Nakamura, T. and Ichikawa, A.: Role of serum in maintenance of functional hepatocytes in primary culture. J. Biochem., 92: 1985-1994 (1982).
18. Yamaoka, K., Tanigawara, Y., Nakagawa, T. and Uno, T.: A pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobio-Dyn., 4: 879-885 (1981).
19. Bogman, K., Peyer, A. K., Torok, M., Kusters and E., Drewe, J.: HMG-CoA reductase inhibitors and P-glycoprotein modulation. Br. J. Pharmacol., 132: 1183-1192 (2001).
20. Yamazaki, M., Akiyama, S., Ni'inuma, K., Nishigaki, R. and Sugiyama, Y.: Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter. Drug Metab. Dispos., 25: 1123-1129 (1997).
21. Fujino, H., Yamada, I., Shimada, S. and Kojima, J.: Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase-Effect of cMOAT deficiency on hepatobiliary excretion in rats and of mdr1a/b gene disruption on tissue distribution in mice. Drug Metab. Phamacokin., 17: 420-427 (2002).
22. Hagenbuch, B., Stieger, B., Foguet, M., Lubbert, H. and Meier, P. J.: Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. Proc. Natl. Acad. Sci., 88: 10629-10633 (1991).
23. Kouzuki, H., Suzuki, H., Ito, K., Ohashi, R. and Sugiyama, Y.: Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes. J. Pharmacol. Exp. Ther., 286: 1043-1050 (1998).
24. Sugiyama, Y., Kimura, S., Lin, J. H., Izukura, M., Awazu, S. and Hanano, M.: Effects of organic anions on the uptake of 1-anilino-8-naphthalenesulfonate by isolated liver cells. J. Pharm. Sci., 72: 871-876 (1983).
25. Cantley, L. C. and Hammes, G. G.: Activation of beef heart mitochondrial adenosine triphosphatase by 2,4-dinitrophenol. Biochem., 12: 4900-4904 (1973).
26. Yamazaki, M., Suzuki, H., Sugiyama, Y., Iga, T. and Hanano, M.: Uptake of organic anions by isolated rat hepatocytes. A classification in terms of ATP-dependen-cy. J. Hepatol., 14: 41-47 (1992).
27. Kouzuki, H., Suzuki, H., Ito, K., Ohashi, R. and Sugiyama, Y.: Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes. J. Pharmacol. Exp. Ther., 288: 627-634 (1999).
28. Abe, T., Kakyo, M., Sakagami, H., Tokui, T., Nishio, T., Tanemoto, M., Nomura, H., Hebert, S. C., Matsuno, S., Kondo, H. and Yawo, H.: Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatpthat transports thyroid hormones and taurocholate and comparison with oatp2. J. Biol. Chem., 273: 22395-22401 (1998).
29. Stremmel, W. and Berk, P. D.: Hepatocellular uptake of sulfobromophthalein and bilirubin is selectively inhibited by an antibody to the liver plasma membrane sulfobromophthalein/bilirubin binding protein. J. Clin. Invest., 78: 822-826 (1986).
30. Kukongviriyapan, V. and Stacey, N. H.: Inhibition of taurocholate transport by cyclosporin A in cultured rat hepatocytes. J. Pharmacol. Exp. Ther., 247: 685-689 (1988).
31. Li, N., Hartley, D. P., Cherrington, N. J. and Klaassen, C. D.: Tissue expression, ontogeny, and inducibility of rat organic anion transporting polypeptide 4. J. Pharmacol. Exp. Ther., 301: 551-560 (2002).
32. Nishio, T., Adachi, H., Nakagomi, R., Tokui, T., Sato, E., Tanemoto, M., Fujiwara, K., Okabe, M., Onogawa, T., Suzuki, T., Nakai, D., Shiiba, K., Suzuki, M., Ohtani, H., Kondo, Y., Unno, M., Ito, S., Iinuma, K., Nunoki, K., Matsuno, S. and Abe, T.: Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D(2), leukotriene C(4), and taurocholate. Biochem. Biophys. Res. Com-mun., 275: 831-838 (2000).
33. Cattori, V., van Montfoort, J. E., Stieger, B., Landmann, L., Meijer, D. K., Winterhalter, K. H., Meier, P. J. and Hagenbuch, B.: Localization of organic anion transporting polypeptide 4 (Oatpin rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch., 443: 188-195 (2001).